Related Experiment Video

Updated: Mar 27, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer

Haiyang Zhang1, Jingjing Duan1, Yanjun Qu1

  • 1Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, 300060, China.

Protein & Cell
|January 14, 2016
PubMed

Insights

MicroRNA-24 (miR-24) promotes gastric cancer (GC) growth by inhibiting the apoptosis regulator BCL2L11. This finding identifies miR-24 as a potential therapeutic target for gastric cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric cancer (GC) is a prevalent malignancy with incompletely understood molecular mechanisms.
  • BCL2L11, a member of the BCL-2 family, is crucial in regulating apoptosis.
  • MicroRNAs (miRNAs) play significant roles in cancer development, but miR-24's function in GC remains uncharacterized.

Purpose of the Study:

  • To investigate the role of miR-24 in gastric cancer.
  • To elucidate the molecular mechanism by which miR-24 influences gastric cancer progression.
  • To assess the potential of miR-24 as a therapeutic target in gastric cancer.

Main Methods:

  • Quantitative real-time PCR to measure miR-24 and BCL2L11 expression in GC tissues.
  • In vitro cell culture experiments assessing cell growth, migration, and apoptosis.
  • In vivo studies to validate the findings.
  • Luciferase reporter assays to confirm direct binding of miR-24 to BCL2L11 mRNA.

Main Results:

  • miR-24 was significantly upregulated in gastric cancer tissues.
  • BCL2L11 expression was inversely correlated with miR-24 levels in GC tissues.
  • Overexpression of miR-24 promoted gastric cancer cell proliferation and migration while inhibiting apoptosis.
  • miR-24 directly targets BCL2L11 mRNA, leading to its downregulation.

Conclusions:

  • miR-24 acts as an oncogenic miRNA in gastric cancer by suppressing BCL2L11.
  • miR-24 promotes tumor growth and metastasis in gastric cancer.
  • miR-24 represents a promising novel therapeutic target for gastric cancer intervention.
Keywords:
BCL2L11cell apoptosisgastric cancermiR-24migrationproliferationtumorigenesis

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K